Tilray Executive and Leadership Team

Irwin Simon, the Chairman & Chief Executive Officer at Tilray, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the research, cultivation, and distribution of medical cannabis, the Chairman & Chief Executive Officer ensures alignment between production capabilities and global market demand. This leadership role involves managing complex relationships with the Board and driving expansion across North American and European territories. By prioritizing innovation in cannabinoid science, Irwin Simon directly impacts the competitive positioning of the company within the pharmaceutical landscape. Through consistent focus on operational excellence, Simon secures sustainable growth and maintains the integrity of the brand. The Chairman & Chief Executive Officer evaluates new acquisition opportunities to broaden the portfolio, ensuring that the company remains at the forefront of the evolving medical cannabis industry while delivering consistent value to stakeholders and patients worldwide.

Carl Merton, the Chief Financial Officer at Tilray, manages the fiscal health and capital allocation strategies for the enterprise. Overseeing financial reporting, investor relations, and budgetary planning, the Chief Financial Officer ensures the company maintains a robust balance sheet to support large-scale cultivation and distribution initiatives. This leadership role involves coordinating with the executive team to optimize resource distribution across international operations. By implementing rigorous financial controls, Carl Merton directly impacts the profitability and market stability of the organization. Through meticulous analysis of market trends, Merton guides the company toward efficient growth and long-term financial viability. The Chief Financial Officer monitors global economic conditions to mitigate risks associated with the pharmaceutical supply chain, ensuring that the company remains well-positioned to capitalize on emerging opportunities within the medical cannabis sector while upholding the highest standards of fiscal transparency and corporate governance.

Blair MacNeil, the President, Canada at Tilray, directs all domestic operations, including the cultivation, production, and distribution of medical cannabis within the Canadian market. Overseeing the regional supply chain and local market engagement, the President, Canada ensures that the company meets the specific needs of the domestic healthcare sector. This leadership role involves navigating the complex regulatory environment of the Canadian pharmaceutical industry to maintain product quality and availability. By optimizing local production capacity, Blair MacNeil directly impacts the market share and brand reputation of the company within the region. Through strategic management of domestic partnerships, MacNeil drives growth and ensures that the company remains a leader in the Canadian cannabis space. The President, Canada collaborates with the broader executive team to align regional initiatives with global objectives, ensuring that the company continues to deliver high-quality cannabinoid solutions to patients and healthcare providers across the country.

Lloyd Brathwaite, the Chief Information Officer at Tilray, architects the digital infrastructure and data security frameworks necessary for global pharmaceutical operations. Overseeing the integration of advanced technology into cultivation and production processes, the Chief Information Officer ensures seamless connectivity across all regional facilities. This leadership role involves protecting sensitive research data and optimizing supply chain visibility through sophisticated software solutions. By modernizing internal systems, Lloyd Brathwaite directly impacts the operational efficiency and technological agility of the company. Through the deployment of scalable cloud platforms, Brathwaite supports the rapid expansion of the medical cannabis distribution network. The Chief Information Officer collaborates with other C-suite leaders to leverage data analytics for improved decision-making, ensuring that the company maintains a competitive edge in the digital age while strictly adhering to international data privacy regulations and pharmaceutical industry standards for information management.

Roger Savell, the Chief Administrative Officer at Tilray, manages the internal organizational structure and corporate support functions that enable efficient business operations. Overseeing human resources, legal compliance, and facility management, the Chief Administrative Officer ensures that all departments operate in accordance with the regulatory requirements of the pharmaceutical industry. This leadership role involves streamlining administrative workflows to support the research and production teams. By fostering a culture of operational discipline, Roger Savell directly impacts the productivity and internal cohesion of the company. Through the implementation of standardized administrative policies, Savell facilitates smooth cross-departmental collaboration across global sites. The Chief Administrative Officer coordinates with the Board to ensure that corporate policies align with the mission of providing high-quality medical cannabis, ultimately strengthening the organizational foundation and ensuring that the company remains agile and responsive to the complex demands of the global healthcare market.